CDEX develops and markets innovative chemical detection technologies with a vision for saving lives and protecting assets. Our patented products use enhanced photoemission spectroscopy to identify and validate substances in difficult-to-monitor environments. With its full-formulary introduction of the ValiMed System in 2007 to validate high-risk medications, CDEX has earned its place as a respected authority in medication safety. The recently debuted ID2 Meth Scanner is CDEX's revolutionary tool in the growing battle against methamphetamine abuse and its toxic impact on the general public.